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Abstract
Background: Extended-spectrum β-lactamases (ESBLs) in Gram-negative organisms is now a major concern in
Enterobacteriaceae worldwide. This study determined a point-prevalence and genetic profiles of ESBL-producing
isolates among members of the family Enterobacteriaceae in Lagos State University Teaching Hospital Ikeja, Nigeria.
Methods: Consecutive non-repetitive invasive multidrug-resistant isolates of the family Enterobacteriaceae obtained
over a period of 1 month (October 2011) were studied. The isolates were identified using VITEK-2/VITEK MS Systems.
Susceptibility testing was performed using E test technique; results were interpreted according to the criteria
recommended by the Clinical and Laboratory Standards Institute (CLSI, 2012). ESBL production was detected
by E test ESBL method and confirmed by polymerase chain reaction (PCR).
Results: During the one-month study period, 38 isolates with ESBL phenotypic characteristics were identified
and confirmed by PCR. Of these, 21 (55.3 %) were E. coli, 12 (31.6 %) K. pneumoniae, 3 (7.9 %) Proteus spp.,
1 (2.6 %) each M. morganii and C. freundii. Thirty (79 %) harbored blaCTX-M genes. Sequence analysis revealed
that they were all blaCTX-M-15 genes. Twenty-nine (96.7 %) of these, also harbored blaTEM genes simultaneously.
All the CTX-M-15-producing isolates carried insertion sequence blaISEcP1 upstream of blaCTX-M-15 genes. The E. coli
isolates were genetically heterogeneous, while the K. pneumoniae had 98 % homology.
Conclusions: Our point-prevalence surveillance study revealed a high prevalence of Enterobacteriaceae isolates
harboring blaCTX-M-15 in the Hospital. Urgent implementation of antibiotic stewardship and other preventive
strategies are necessary at this time in our hospital.
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Background
Gram-negative organisms belonging to the family
Enterobacteriacae commonly produce beta-lactamases,
which confer resistance to most penicillins but not to
expanded-spectrum cephalosporins. The genes encoding
these beta-lactamases are plasmid-borne, and belong to the
TEM-1, TEM-2, and SHV-1 types [1]. Infections caused by
members of the family Enterobacteriaceae are treated
with cephalosporins, particularly the third-and fourth-
generation cephalosporins. However, resistance to these
drugs has emerged throughout the world with widespread
of resistant strains. By the middle of the 80s, resistance to
the expanded-spectrum cephalosporin became evident and
various studies have shown that the resistance was
mediated by structural mutation in the older enzymes [1, 2].
In Enterobacteriaceae, resistance to cephalosporin is
commonly due to production of extended-spectrum
β-lactamases (ESBLs). The emergence of ESBLs in Gram-
negative organisms is now a major concern worldwide [1],
and the presence of these enzymes is among the most
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important resistance determinants to have emerged in
Enterobacteriaceae [3–7]. Most ESBLs are derivatives
of TEM and SHV β-lactamase families. Other groups
such as PER and CTX-M types have been described
[8, 9]. In addition, other β-lactamases, including those
belonging to Ambler class B (metallo-β-lactamase), class
A (e.g. KPC) or class D (OXA-48), capable of hydrolyzing
carbapenems have emerged [10–12].
The literature is awash with evidence of global dis-
semination of CTX-M type ESBL of pandemic proportion
[9, 13, 14]. The production of this enzyme is mediated by
the blaCTX-M gene, which confers resistance to the third-
generation cephalosporins particularly in Escherichia coli
and Klebsiella spp. [15]. Several phenotypic and genotypic
studies have documented the emergence of CTX-M-type
extended-spectrum β-lactamases as well as the genes
encoding their production in Enterobacteriaceae, in
Nigeria. However, most of these studies have been on
randomly selected E. coli and K. pneumoniae [16–19]
and Salmonella enterica serovar Typhi [20] and thus
the true prevalence of CTX-M in most parts of the
country is unknown. In our hospital, cephalosporins
are first line antibiotics used in the treatment of
Gram-negative sepsis and other infective conditions.
A previous study conducted earlier in the same hospital
demonstrated high resistance rates among clinically sig-
nificant species of the family Enterobacteriaceae against
the cephalosporins and other β-lactam antibiotics [21].
With such high resistance rates, it is conceivable that
CTX-M would also be the dominant ESBL type respon-
sible for this high level of resistance in our hospital.
This study was undertaken to investigate a point-
prevalence and genetic profiles of ESBL-producing iso-
lates among members of the family Enterobacteriaceae
causing infections in patients on admission in a tertiary
hospital in Lagos.
Methods
Bacterial isolates and setting
Thirty-eight consecutive isolates of multidrug-resistant
invasive species of the family Enterobacteriaceae were
obtained over a period of one month (October 2011),
during routine laboratory investigation, from in-patients at
the Lagos State University Teaching Hospital (LASUTH)
located in Ikeja, a suburban part of Lagos. The hospital
serves as a referral center for about 6 million Lagosians. It
has one adult Intensive Care Unit (ICU), 1 Critical Care
Unit (CCU), a dialysis unit and an oncology unit. The
age, sex, nationality, previous hospital admissions, and
documented travel history were all carefully noted.
Duplicate isolates were omitted from the study.
The bacterial isolates were identified by VITEK-2
system (bioMérieux, Hazelwood, MO, USA). In addition,
when necessary, further confirmation was carried out with
VITEK MS, a matrix-assisted laser desorption ionization-
time of flight (MALDI-TOF) mass spectrometry (MS)
system (bioMerieux, Marcy-l’Etoile, France).
Susceptibility testing
Susceptibility testing of the isolates was performed by
determining the minimum inhibitory concentrations
(MICs) of amikacin, amoxicillin-clavulanic acid, cefepime,
cefotaxime, cefoxitin, ceftazidime, ciprofloxacin, colis-
tin, ertapenem, imipenem, gentamicin, meropenem,
piperacillin-tazobactam, and tigecycline on Mueller-Hinton
agar plates using E test (bioMerieux) technique. A quality
control strain, Escherichia coli ATCC 25922 was included
in each run. The results were interpreted according to the
break-points and criteria recommended by the Clinical and
Laboratory Standards Institute (CLSI, 2012) [22].
Confirmation of ESBL
All the ESBL-producing isolates were phenotypically
detected by E test ESBL method using cefotaxime
(CT)/cefotaxime combined with clavulanic acid (CTL) and
ceftazidime (TZ)/ceftazidime combined with clavulanic acid
(TZL) (bioMerieux) and were confirmed by polymerase
chain reaction (PCR). In-house ESBL-producing E. coli
strain K31 [23] and ESBL-negative strain were included in
the test runs as positive and negative controls, respectively.
PCR amplification and sequencing
PCR assays were carried out with a series of primers to
detect the following genes mediating blaSHV, blaTEM,
blaCMY-6, blaCMY-4, and blaCTX-M [24]. PCR products were
sequenced with a 3130xl Genetic Analyzer (Applied
Biosystems, Hitachi High-Technologies Corporation, Tokyo,
Japan). Sequences were compared and aligned with
reference sequences available in the GenBank.
Detection of insertion sequence, ISEcp1
The genetic organization of the blaISEcp1 was investigated by
sequencing this short segment using the following primers:
ISEcp1A (5’-GCA GGT CTT TTT CTG CTC C-3’) and
ISEcp1B (5’- ATT TCC GCA GCA GCA CCG TTT
GC- 3’) [25].
Genotyping of isolates
Fifteen randomly selected strains of the blaCTX-M-15-
positive isolates (9 E. coli and 6 K. pneumoniae) were
investigated for genetic relatedness using pulsed-field
gel electrophoresis (PFGE) with Xba1 digestion of the
genomic DNA separated by electrophoresis in 1.2 %
agarose gel [26] and the strains compared by differences
in number and mobility of the bands.
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Results
During this one month study, a total of 73 isolates
belonging to the family Enterobacteriaceae were studied.
Of these, 38 (52.1 %) were ESBL-producing isolates, 21
(55.3 %) of which were E. coli, 12 (31.6 %) K. pneumoniae,
3 (7.9 %) Proteus spp., 1 each (2.6 %) M. morganii and
Citrobacter freundii. They were isolated from urine (24),
wound swabs (8), blood culture (3) and respiratory secre-
tions (3). These specimens were obtained from infected
in-patients who were ethnic Nigerians, predominantly
Yorubas. Their ages ranged from 6 – 89 years (mean
59.2 years); 20 (52.6 %) were males and 18 (47.4 %)
females with a male-to-female ratio of 1.1:1.
Prevalence of blaCTX-M ESBL-positive Enterobacteriaceae
The ESBL-producing E. coli and K. pneumoniae were
multidrug-resistant isolates (MDR) showing resistance to
five or more antibiotics (Table 1). The number of MDR
P. mirabilis, M. morganii and C. freundii isolates was
too small for any analysis.
As shown in Table 2, of the 38 ESBL-producing isolates,
30 (79 %) harbored blaCTX-M genes. Sequence analysis of
these genes revealed that they were all blaCTX-M-15.
Twenty-nine (96.7 %) of these, also harbored blaTEM genes
simultaneously. A combination of blaCTX-M-15, blaTEM
and blaSHV were found in 6 isolates; the distribution of
the blaSHV was blaSHV-11 (2), blaSHV-12 (2) and blaSHV-112
(2). All 30 isolates positive for blaCTX-M carried insertion
sequence blaISEcP1 upstream of the blaCTX-M-15 genes.
The ESBL E-test for ESBL production detected all the
blaCTX-M, blaTEM and blaSHV-positive isolates confirmed
by PCR. Testing both cefotaxime and ceftazidime was
necessary for detection of CTX-M-positive isolates. As
demonstrated in Table 1, the MIC90s of the third-generation
cephalosporins were all >256 μg/ml. Our blaCTX-M-positive
isolates, with or without SHV and TEM, were susceptible to
amikacin, colistin, imipenem, meropenem and tigecycline.
Three isolates (2 E. coli and 1K. pneumoniae) were not
inhibited at the cut-off breakpoint (0.5 μg/ml) of ertapenem
but were susceptible to imipenem (MIC = 0.125 and
0.5 μg/ml) and meropenem (0.5 and 0.75 μg/ml). There
was no specific distribution of the CTX-M-15-positive
isolates among ethnic groups of the Yoruba race. Two E.
coli and a Proteus spp. isolates were positive for ESBL but
the genes encoding their production were not detected.
Clonal relatedness of the blaCTX-M-15 harboring isolates
The fingerprinting of the genomic DNA of the
blaCTX-M-15-positive randomly selected isolates of E.
coli and K. pneumoniae showed that the E. coli isolates
were genetically heterogeneous, as the isolates did not fall
within a particular cluster. On the other hand, there was
about 98 % similarity with the K. pneumoniae isolates.
Discussion
The predominant genotype of the ESBL found in the
clinical isolates of Enterobacteriaceae in this study
was blaCTX-M-type genes with all being blaCTX-M-15;
over 96 % of these 38 isolates also harbored a blaTEM
β-lactamase gene. Five isolates co-harbored narrow-
spectrum blaSHV-11 and other blaSHV genes. Our data
demonstrate a very high prevalence of blaCTX-M type
ESBL genes among the multidrug-resistant (MDR)
isolates studied. This lends credence to the worldwide
pandemic spread of the CTX-M β-lactamase enzyme,
a phenomenon that has reached epidemic proportion
among members of the family Enterobacteriaceae. The
ESBL mediated by blaCTX-M type β-lactamase genes are
Table 1 Antibiotic susceptibility profiles of the blaCTX-M
ESBL-positive E. coli and K. pneumoniae.
Antibiotics MIC (μg/ml) for the blaCTX-M-positive isolates:
E. coli K. pneumoniae
(n = 18) (n = 10)
MIC50 MIC90 MIC50 MIC90
Amikacin 2 16 0.5 4
Ampicillin >256 >256 >256 >256
Amoxicillin-clavulanate 6 16 8 16
Aztreonam >256 >256 >256 >256
Cefepime >256 >256 >256 >256
Cefotaxime >256 >256 >256 >256
Cefoxitin 2 12 4 12
Ceftazidime 32 >256 >256 >256
Cefuroxime >256 >256 >256 >256
Ciprofloxacin >32 >32 >32 >32
Colistin 0.002 2 0.064 1.5
Ertapenem 0.0125 0.75 0.064 0.5
Gentamicin 1 16 0.5 >256
Imipenem 0.125 0.75 0.125 0.25
Meropenem 0.094 0.125 0.047 1
Piperacillin-tazobactam 0.75 >256 0.5 >256
Tigecycline 0.5 1.5 0.125 1




No. (%) of ESBL-
positives (n = 38)
No. (%) of isolates harboring bla genes:
blaCTX-M-15 blaTEM-1 blaSHV
(n = 30) (n = 29) (n = 6)
E. coli 21 (55.3) 18 (60.0) 17 (58.6) 2 (33.3)
K. pneumoniae 12 (31.6) 10 (33.3) 9 (31.0) 2 (33.3)
P. mirabilis 3 (7.9) 2 (6.7) 3 (10.4) 0 (0)
M. morganii 1 (2.6) 0 (0) 0 (0) 1 (16.7)
C. freundii 1 (2.6) 0 (0) 0 (0) 1 (16.7)
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undoubtedly the most widespread enzymes produced
among members of this family. This assertion is predi-
cated on the fact that over 79 % of our ESBL-producing
isolates harbored blaCTX-M, the gene that mediates
CTX-M enzyme production. Remarkably, all the
CTX-M enzymes were CTX-M-15, making this type
of β-lactamase the most common type detected in
Enterobacteriaceae in this Lagos hospital. The dominance
of blaCTX-M-15 β-lactamase genes in our snap surveillance
study confirms what other workers had earlier reported in
North America [15, 27, 28], Europe [29, 30], South
America [31] the Middle East [23, 32] and Nigeria
[16–20]. This ESBL gene has also been incriminated in
community outbreaks of multidrug resistant (MDR) E. coli
infections in some parts of the UK [30] and elsewhere [15].
The literature on the genetic characteristics of ESBLs
in Nigeria and, indeed, Africa is sparse. The data
emanating so far from Nigeria does not include the
prevalence of the CTX-M ESBL in an in-patient setting.
With this study we have demonstrated that the prevalence
of Enterobacteriaceae isolates carrying genes that encode
CTX-M-15 ESBL enzymes is at an unacceptable level
with potential clinical and financial implications for
the hospital.
The clinical implication of this finding is that many
patients infected by MDR Gram-negative bacteria stand
the risk of treatment failure and cases of fatalities may
increase. Thus, treatment of such infections assumes
a great challenge to the clinician and the clinical
microbiologists as treatment options are limited to
very expensive and sometimes toxic drugs. Added to
this burden is the fact that the location of the mobile
genetic element, ISEcp1, a single copy insertion sequence
responsible for mobilization of bla genes, was found
upstream of the blaCTX-M genes. This has grave con-
sequences as it might conceivably facilitate the spread
of these genes among the Enterobacteriaceae within
the hospital. Transfer of the blaCTX-M-15 genes to recipient
E. coli J53 has been shown to be quite readily achievable.
This suggests that resistance genes can easily move from
one species to another with the possibility of easy inter-
species transfer. One of the limitations of this study was
that plasmids were not studied to determine if these genes
were the same.
Conclusion
In conclusion, our study demonstrated an explosive
emergence of isolates harboring blaCTX-M-15 gene
mediating CTX-M-type ESBL production in invasive
members of family Enterobacteriaceae. Immediate
implementation of antibiotic stewardship and other
preventive strategies are necessary to stem the tide
of dangerous spread of MDR Enterobacteriaceae in
this Lagos hospital.
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